Zomedica Corp. Selling and Marketing Expense
Zomedica Corp. (ZOMDF) reported Selling and Marketing Expense of $3.67 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingAndMarketingExpense · last filed 2026-08-05
- Zomedica Corp. selling and marketing expense for the quarter ending 2026-06-30 was $3.67M, a 21.02% decline year-over-year.
- Zomedica Corp. selling and marketing expense for the quarter ending 2026-03-31 was $3.82M, a 23.77% decline year-over-year.
- Zomedica Corp. selling and marketing expense for the quarter ending 2025-12-31 was $4.52M, a 14.28% decline year-over-year.
- Zomedica Corp. selling and marketing expense for the quarter ending 2025-09-30 was $4.36M, a 12.03% increase year-over-year.
- Zomedica Corp. selling and marketing expense for fiscal 2025 was $18.54M, a 7.82% increase from fiscal 2024.
- Zomedica Corp. selling and marketing expense for fiscal 2024 was $17.19M, a 21.61% increase from fiscal 2023.
- Zomedica Corp. selling and marketing expense for fiscal 2023 was $14.14M, a 43.10% increase from fiscal 2022.
- Zomedica Corp. selling and marketing expense for fiscal 2022 was $9.88M.
| Period end | Selling and Marketing Expense 3 month | Selling and Marketing Expense 6 month | Selling and Marketing Expense 9 month | Selling and Marketing Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $3.67M 10-Q · filed 2026-08-05 | $7.49M 10-Q · filed 2026-08-05 | $12.01M derived: sum of 3 quarters · filed 2026-08-05 | $16.37M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $3.82M 10-Q · filed 2026-05-06 | $8.34M derived: sum of 2 quarters · filed 2026-05-06 | $12.69M derived: sum of 3 quarters · filed 2026-05-06 | $17.35M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $4.52M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $8.88M derived: sum of 2 quarters · filed 2026-03-16 | $13.53M derived: sum of 3 quarters · filed 2026-08-05 | $18.54M 10-K · filed 2026-03-16 |
| 2025-09-30 | $4.36M 10-Q · filed 2025-11-04 | $9.01M derived: sum of 2 quarters · filed 2026-08-05 | $14.02M 10-Q · filed 2025-11-04 | $19.29M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $4.65M 10-Q · filed 2026-08-05 | $9.66M 10-Q · filed 2026-08-05 | $14.93M derived: sum of 3 quarters · filed 2026-08-05 | $18.82M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $5.01M 10-Q · filed 2026-05-06 | $10.28M derived: sum of 2 quarters · filed 2026-05-06 | $14.17M derived: sum of 3 quarters · filed 2026-05-06 | $18.09M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $5.27M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $9.16M derived: sum of 2 quarters · filed 2026-03-16 | $13.09M derived: sum of 3 quarters · filed 2026-03-16 | $17.19M 10-K · filed 2026-03-16 |
| 2024-09-30 | $3.89M 10-Q · filed 2025-11-04 | $7.81M derived: sum of 2 quarters · filed 2025-11-04 | $11.92M 10-Q · filed 2025-11-04 | $16.23M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $3.92M 10-Q · filed 2025-08-06 | $8.03M 10-Q · filed 2025-08-06 | $12.34M derived: sum of 3 quarters · filed 2025-08-06 | $15.67M derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | $4.11M 10-Q · filed 2025-05-15 | $8.42M derived: sum of 2 quarters · filed 2025-05-15 | $11.75M derived: sum of 3 quarters · filed 2025-05-15 | $14.83M derived: sum of 4 quarters · filed 2025-05-15 |
| 2023-12-31 | $4.31M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-13 | $7.64M derived: sum of 2 quarters · filed 2025-03-13 | $10.72M derived: sum of 3 quarters · filed 2025-03-13 | $14.14M 10-K · filed 2025-03-13 |
| 2023-09-30 | $3.33M 10-Q · filed 2024-11-07 | $6.41M derived: sum of 2 quarters · filed 2024-11-07 | $9.83M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $3.08M 10-Q · filed 2024-08-14 | $6.50M 10-Q · filed 2024-08-14 | ||
| 2022-12-31 | $3.41M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $7.15M derived: sum of 2 quarters · filed 2024-04-01 | $9.88M 10-K · filed 2024-04-01 | |
| 2022-09-30 | $3.73M 10-Q · filed 2023-11-13 | $6.47M 10-Q · filed 2023-11-13 |